Nanordica Medical

Nanordica Medical

Develops first-in-class antibacterial wound care products.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor investor investor

€0.0

round
*

€1.8m

Seed
Total Funding000k
More about Nanordica Medical
Made with AI
Edit

The only company in the world developing first-in-class wound care products based on synergistic nanoparticles that manage infection and support wound healing simultaneously, leading to faster wound closure. Nanordica Medical recently completed a randomized active-controlled clinical study on patients with severe wounds (diabetic foot ulcers) that showed that their solution healed wounds 2 times faster than the standard of care, including hard-to-heal wounds. In 2023, their solution was awarded a highly competitive EIC Accelerator grant that supports top innovators in the EU.

Keywords: Healthcare Devices, Services, Supplies, Antibacterial Devices, Antibacterial Product, Antibacterial Products, Healthcare Hardware, Healthcare Product, Medical Equipment, Medical Equipment Retail.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads